Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids
Oldenmenger WH, Lieverse PJ, Janssen PJJM, Taal W, van der Rijt CCR, Jager A. Supportive Care Cancer 2012; 20: 1639-47
The authors report a retrospective study on 104 consecutive advanced cancer patients who were extensively pre-treated with one or more opioids with inadequate nociceptive pain control (pain intensity > 4 on a 0-10 numerical scale) or intolerable (moderate to severe) side effects who were then rotated to parenteral hydromorphone. After starting parenteral administration of hydromorphone, the pain intensity at rest and upon movement, and any side effects were recorded twice each day. The moment that adequate pain control was reached was defined as the first day of at least 2 consecutive days with a reported mean pain score of 4 or less.
The main reasons for rotation to parenteral hydromorphone were inadequate pain control combined with/without expected delivery problems due to high opioid dosages and intolerable side effects with persistent pain.
Before starting parenteral hydromorphone, 18% of the patients used morphine, and 76% used fentanyl; 88% had been treated with two or more opioid rotations with various drugs. Before switching to intravenous (13 patients) or subcutaneous hydromorphone (91 patients), the median oral morphine equivalent daily dose was 600 mg/day (range 72 - 2,592 mg/day). The median oral dose of hydromorphone at start was 48 mg/day (range 5-216). Adequate pain control was achieved in 5 days in 83% of the patients and their mean pain intensity at rest decreased from 5.4 to 2.4 (p<0.001) whereas pain on movement decreased from 7.4 to 3.8 (p<0.001). Eight of 86 patients still had side effects. Among the 86 patients who achieved adequate pain control on parenteral hydromorphone, only 17% rotated to oral or transdermal opioids, 11 patients rotated to spinal analgesia and 1 received a nerve block.
Why I chose this article
Opioid rotation is the process of switching from one opioid to another opioid when side effects, and/or analgesic ineffectiveness or tolerance develops. By means of the sequential administration of different opioids, it is possible to act on different subtypes of opioid receptors, thus improving the symptoms and reducing tolerance. Patients who have poor analgesic efficacy or tolerability with one opioid can frequently tolerate another opioid well, although the mechanisms that underlie this variability to different opioids are not known. Different explanations on the role of opioid switching have been proposed, such as genetic makeup, tolerance to different opioid effects, the incomplete cross-tolerance among opioids selective for the same receptor subtype due to differential affinity for receptor subtypes, the differences in profile of active metabolites between various opioids and the pain mechanism. The ideal alternative opioid has not been characterized. However high potency parenteral opioids administered intravenously or subcutaneously are indicated for rapid titration in case of severe pain where oral route might not be indicated and/or for patients who need rapid dose escalation. Hydromorphone is an analogue of morphine with similar pharmacokinetic and pharmacodynamic properties, but about 5 times more potent. Parenteral hydromorphone may be a valid solution when a switch of the opioid is indicated.
Reviewed by Dr. Carla Ripamonti (Italy).
Dr. Ripamonti is a life time adviser to the IAHPC Board and her bio may be viewed here.
Help us to help others: IAHPC's annual fundraiser!
How your gift supports the IAHPC mission
Achieved: $24,941
Goal: $30,000
83%
Education
Your gift funds the operational costs of our online courses taught by globally recognized experts who volunteer their time and provide educational resources relevant to palliative care topics. It also supports scholarships that enable palliative care workers to attend educational events and congresses, and allows us to maintain Pallipedia, the free, live, online dictionary.
The goal of this pillar is to implement strategies, resources and tools that will improve the competencies of the global workforce for appropriate palliative care delivery. We have two programs under this pillar plus many other resources for our members.
Your gift enables us to build and strengthen the partnerships that accelerate global, regional, and national advocacy for palliative care. We advocate for its integration into primary health care under universal health coverage and effective access to essential palliative care medicines and packages for people of all ages. Your gift supports our work to prepare delegates and participate in technical consultation meetings of the relevant UN organizations.
The goal this pillar is the integration of palliative care into primary health care within the spectrum of universal coverage to improve access to adequate care for patients in need. We offer the following to our members:
Documents on Human Rights and Access to Medicines and Care
Research
Your gift enables us to continue doing research that provides guidance and recommendations for action, based on responses from the global palliative care community. Such research includes our recent evaluation of the impact of euthanasia and assisted dying practices on palliative care workers and the use of essential medicines for palliative care. It also supports the costs of publications focused on research relevant to palliative care.
The goal of this pillar is to design and implement projects that lead to the integration of palliative care into health policies, resolutions, and key documents. Our studies help us provide guidance and recommendations, and take action based on the responses from the global palliative care community.
Your membership enables you to participate in IAHPC projects such as the:
Your gift enables us to continue our in-depth reporting and book reviews in Pallinews, as well as media campaigns that raise awareness about the need to increase access to care and support for patients and families.
We are a small organization that allocates over 80% of our budget to mission driven programs and to the maintenance of our free website. We need operational funding to continue the work.
Give a gift, get a gift
IAHPC members: When you gift a 2-year membership to a colleague in a low- or middle-income country, we extend your membership by 6 months.